Annual Net Income
-$201.59 M
-$3.87 M-1.96%
December 31, 2023
Summary
- As of February 7, 2025, PHAT annual net profit is -$201.59 million, with the most recent change of -$3.87 million (-1.96%) on December 31, 2023.
- During the last 3 years, PHAT annual net income has fallen by -$72.52 million (-56.19%).
- PHAT annual net income is now -15551.55% below its all-time high of -$1.29 million, reached on December 31, 2018.
Performance
PHAT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$85.58 M
+$5.87 M+6.42%
September 30, 2024
Summary
- As of February 7, 2025, PHAT quarterly net profit is -$85.58 million, with the most recent change of +$5.87 million (+6.42%) on September 30, 2024.
- Over the past year, PHAT quarterly net income has increased by +$5.87 million (+6.42%).
- PHAT quarterly net income is now -29409.31% below its all-time high of -$290.00 thousand, reached on September 30, 2018.
Performance
PHAT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$339.44 M
-$42.33 M-14.25%
September 30, 2024
Summary
- As of February 7, 2025, PHAT TTM net profit is -$339.44 million, with the most recent change of -$42.33 million (-14.25%) on September 30, 2024.
- Over the past year, PHAT TTM net income has dropped by -$42.33 million (-14.25%).
- PHAT TTM net income is now -116950.00% below its all-time high of -$290.00 thousand, reached on September 30, 2018.
Performance
PHAT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
PHAT Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.0% | +6.4% | -14.3% |
| 3 y3 years | -56.2% | -55.5% | -71.7% |
| 5 y5 years | -10000.0% | -55.5% | -71.7% |
PHAT Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.1% | at low | -138.9% | +6.4% | -135.9% | at low |
| 5 y | 5-year | -56.2% | +21.0% | -324.9% | +12.7% | -163.0% | at low |
| alltime | all time | <-9999.0% | +21.0% | <-9999.0% | +12.7% | <-9999.0% | at low |
Phathom Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$85.58 M(-6.4%) | -$339.44 M(+14.2%) |
| Jun 2024 | - | -$91.45 M(+10.4%) | -$297.11 M(+20.5%) |
| Mar 2024 | - | -$82.85 M(+4.1%) | -$246.63 M(+22.3%) |
| Dec 2023 | -$201.59 M(+2.0%) | -$79.57 M(+84.0%) | -$201.59 M(+13.8%) |
| Sep 2023 | - | -$43.24 M(+5.6%) | -$177.07 M(-4.2%) |
| Jun 2023 | - | -$40.97 M(+8.3%) | -$184.92 M(-5.1%) |
| Mar 2023 | - | -$37.81 M(-31.3%) | -$194.87 M(-1.4%) |
| Dec 2022 | -$197.72 M(+37.4%) | -$55.05 M(+7.7%) | -$197.72 M(+10.8%) |
| Sep 2022 | - | -$51.09 M(+0.3%) | -$178.50 M(+8.8%) |
| Jun 2022 | - | -$50.92 M(+25.2%) | -$164.07 M(+9.6%) |
| Mar 2022 | - | -$40.66 M(+13.5%) | -$149.71 M(+4.0%) |
| Dec 2021 | -$143.88 M | -$35.83 M(-2.3%) | -$143.88 M(-11.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$36.66 M(+0.3%) | -$161.78 M(+1.6%) |
| Jun 2021 | - | -$36.55 M(+4.9%) | -$159.22 M(+10.7%) |
| Mar 2021 | - | -$34.84 M(-35.1%) | -$143.77 M(+11.4%) |
| Dec 2020 | -$129.07 M(-49.4%) | -$53.72 M(+57.5%) | -$129.07 M(-25.5%) |
| Sep 2020 | - | -$34.10 M(+61.6%) | -$173.35 M(-16.4%) |
| Jun 2020 | - | -$21.10 M(+4.8%) | -$207.36 M(-24.3%) |
| Mar 2020 | - | -$20.14 M(-79.4%) | -$274.02 M(+7.4%) |
| Dec 2019 | -$255.13 M(>+9900.0%) | -$98.01 M(+43.9%) | -$255.13 M(+61.9%) |
| Sep 2019 | - | -$68.11 M(-22.4%) | -$157.61 M(+75.5%) |
| Jun 2019 | - | -$87.76 M(+6915.3%) | -$89.79 M(+4333.9%) |
| Mar 2019 | - | -$1.25 M(+158.5%) | -$2.02 M(+161.6%) |
| Dec 2018 | -$1.29 M | -$484.00 K(+66.9%) | -$774.00 K(+166.9%) |
| Sep 2018 | - | -$290.00 K | -$290.00 K |
FAQ
- What is Phathom Pharmaceuticals annual net profit?
- What is the all time high annual net income for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals annual net income year-on-year change?
- What is Phathom Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals quarterly net income year-on-year change?
- What is Phathom Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals TTM net income year-on-year change?
What is Phathom Pharmaceuticals annual net profit?
The current annual net income of PHAT is -$201.59 M
What is the all time high annual net income for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high annual net profit is -$1.29 M
What is Phathom Pharmaceuticals annual net income year-on-year change?
Over the past year, PHAT annual net profit has changed by -$3.87 M (-1.96%)
What is Phathom Pharmaceuticals quarterly net profit?
The current quarterly net income of PHAT is -$85.58 M
What is the all time high quarterly net income for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high quarterly net profit is -$290.00 K
What is Phathom Pharmaceuticals quarterly net income year-on-year change?
Over the past year, PHAT quarterly net profit has changed by +$5.87 M (+6.42%)
What is Phathom Pharmaceuticals TTM net profit?
The current TTM net income of PHAT is -$339.44 M
What is the all time high TTM net income for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high TTM net profit is -$290.00 K
What is Phathom Pharmaceuticals TTM net income year-on-year change?
Over the past year, PHAT TTM net profit has changed by -$42.33 M (-14.25%)